Product Program year 2023 Source: CMS Open Payments

Biodesign

Device Tissue Therapies

PDI 10827002314556

Open in the dashboard

General payments

$14,907

102 payments

Research payments

$0

0 payments

Through program year 2023, $14,907 in general payments and $0 in research payments were reported against Biodesign (Tissue Therapies).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $14,907 102

Breakdown

Who paid General payments · program year 2023
  1. Cook Biotech Incorporated $14,907 102 payments
Top recipients General payments · program year 2023
  1. Jenny Speranza Colon & Rectal Surgery · Rochester, NY $967 6% · 3 payments
  2. Talar Tejirian Surgery · Los Angeles, CA $884 6% · 4 payments
  3. Victoria Murdock Surgery · Anchorage, AK $554 4% · 2 payments
  4. Lisa Parry Surgery · San Diego, CA $554 4% · 1 payment
  5. James Bittner Surgery · Suffolk, VA $448 3% · 4 payments

The top 5 of 85 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Surgery $8,951 60% · 45 practitioners
  2. Colon & Rectal Surgery $4,502 30% · 23 practitioners
  3. Trauma Surgery Surgery $277 2% · 1 practitioner
  4. Surgical Critical Care Surgery $277 2% · 1 practitioner
  5. Obstetrics & Gynecology $136 <1% · 1 practitioner

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Illinois $2,667 18% · 21 recipients
  2. California $1,611 11% · 3 recipients
  3. Virginia $1,556 10% · 5 recipients
  4. Massachusetts $1,386 9% · 8 recipients
  5. Michigan $1,301 9% · 6 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

102 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record